Maynard Um
-
-
-
-
-
-
-
Barclays Double Downgrades Janux Therapeutics (JANX) to Underweight
-
-
-
-
-
-
-
Janux Therapeutics (JANX) Reiterated at Buy by UBS After JANX007 Ph1 update
-
-
-
-
-
-
-
Janux Therapeutics (JANX) PT Lowered to $65 at Jones Trading
-
-
-
-
-
-
-
Piper Sandler Starts Janux Therapeutics (JANX) at Overweight
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Janux Therapeutics (JANX)
-
-
-
-
-
-
-
Janux Therapeutics (JANX) PT Raised to $105 at Jones Trading
-
-
-
-
-
-
-
Janux Therapeutics (JANX) call put ratio 1 call to 2.8 puts into data
-
404,878 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

